BL-918 alleviates oxidative stress in rats after subarachnoid hemorrhage by promoting mitophagy through the ULK1/PINK1/Parkin pathway

Free Radic Biol Med. 2024 Nov 1:224:846-861. doi: 10.1016/j.freeradbiomed.2024.10.261. Epub 2024 Oct 4.

Abstract

Background and purpose: Oxidative stress plays a critical role in early brain injury (EBI) following subarachnoid hemorrhage (SAH). The small molecule ULK1 agonist, BL-918, demonstrated neuroprotective effects in other central nervous system diseases; however, its role in SAH has not yet been explored. This study aimed to evaluate whether BL-918 could provide neuroprotective effects in rats following SAH.

Methods: An SAH model was established in Sprague-Dawley rats using endovascular perforation. BL-918 was administered intraperitoneally after SAH, while the ULK1 inhibitor SBI was given intraperitoneally prior to SAH modeling. PINK1 siRNA was administered into the lateral ventricle before SAH induction. The neuroprotective effects and mechanisms of BL-918 were assessed through SAH grading, brain water content measurement, blood-brain barrier permeability, neurobehavioral tests, Western blot, immunofluorescence, TUNEL staining, DHE staining, and transmission electron microscopy (TEM).

Results: After SAH, the expression levels of p-ULK1, PINK1, Parkin, and LC3Ⅱ increased, peaking at 24 h post-SAH. BL-918 treatment improved neurological function in rats, reduced brain water content and blood-brain barrier permeability, and exhibited anti-oxidative stress and anti-apoptotic effects. Western blot analysis revealed that BL-918 increased the expression of p-ULK1, PINK1, Parkin, LC3Ⅱ, Bcl-xl, and Bcl-2 while inhibiting the expression of Bax and Cleaved Caspase-3. Oxidative stress-related indicators showed that BL-918 alleviated oxidative stress. Immunofluorescence and TEM results demonstrated that BL-918 promoted mitophagy and preserved mitochondrial morphology. Furthermore, the positive effects of BL-918 were reversed by SBI and PINK1 siRNA, respectively.

Conclusion: BL-918 improved both short-term and long-term neurological impairments in rats after SAH and reduced oxidative stress by promoting mitophagy, at least partially through the ULK1/PINK1/Parkin signaling pathway.

Keywords: Early brain injury; Mitophagy; Oxidative stress; Subarachnoid hemorrhage.

MeSH terms

  • Animals
  • Apoptosis
  • Autophagy-Related Protein-1 Homolog* / genetics
  • Autophagy-Related Protein-1 Homolog* / metabolism
  • Blood-Brain Barrier* / drug effects
  • Blood-Brain Barrier* / metabolism
  • Disease Models, Animal
  • Male
  • Mitophagy* / drug effects
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress* / drug effects
  • Phenylacetates
  • Protein Kinases* / genetics
  • Protein Kinases* / metabolism
  • Rats
  • Rats, Sprague-Dawley*
  • Signal Transduction
  • Subarachnoid Hemorrhage* / complications
  • Subarachnoid Hemorrhage* / drug therapy
  • Subarachnoid Hemorrhage* / genetics
  • Subarachnoid Hemorrhage* / metabolism
  • Subarachnoid Hemorrhage* / pathology
  • Ubiquitin-Protein Ligases* / genetics
  • Ubiquitin-Protein Ligases* / metabolism

Substances

  • PTEN-induced putative kinase
  • parkin protein
  • Ubiquitin-Protein Ligases
  • Protein Kinases
  • Autophagy-Related Protein-1 Homolog
  • ULK1 protein, rat
  • Neuroprotective Agents
  • BL-918
  • Phenylacetates